Effects of acetyl-L-carnitine on regional cerebral glucose metabolism in awake rats

被引:19
|
作者
Ori, C
Freo, U
Pizzolato, G
Dam, M
机构
[1] Univ Padua, Dept Anesthesiol, Padua, Italy
[2] Univ Padua, Dept Neurol, Padua, Italy
关键词
memory; deoxyglucose; carnitine; rat;
D O I
10.1016/S0006-8993(02)03290-0
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The time-course and relation to dose of regional metabolic rates for glucose (rCMRglc) were measured in awake adult Fischer-344 rats after administration of acetyl-L-carnitine (ALCAR), an agent that modulates neuronal energy processes and neurotransmitter synthesis. rCMRglc were determined with the quantitative [C-14]2-deoxy-D-glucose technique in 50 brain regions at 10, 30 and 60 min after i.v. administration of ALCAR 500 mg/kg and at 30 min after ALCAR 250 and 700 mg/kg or coadministration of acetate (500 mg/kg) and carnitine (500 mg/kg). ALCAR resulted in significant rCMRglc increases that were maximal by 30 min; by that time, ALCAR 250 produced small, non-significant increase in rCMRglc (no region affected, mean increase 13%) and ALCAR 500 and 750 similar, larger increases in rCMRglc (eight and 11 brain regions affected, mean increases 21 and 22%, respectively). In contrast with ALCAR, carnitine plus acetate did not alter significantly rCMRglc in any brain regions, suggesting that acetate metabolism and carrier are not involved in ALCAR pharmacological activities. ALCAR increased rCMRglc more markedly in subcortical cholinergic (i.e. diagonal band, preoptic magnocellular area) and non-cholinergic (i.e. locus coeruleus, median raphe) nuclei and, to a lesser degree, in limbic and sensorimotor cortical areas. The topographic distribution of rCMRglc increases induced by ALCAR differs from those produced by cholinergic muscarinic agonists and suggest a preferential activation of nicotinic receptors. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:330 / 335
页数:6
相关论文
共 50 条
  • [41] Enantioselective synthesis of L-carnitine and acetyl-L-carnitine hydrochlorides
    Cheng, Qing-Fang
    Xu, Xing-You
    Li, Yan-Hui
    Wang, Jian
    Yao, Yong
    CHINESE JOURNAL OF ORGANIC CHEMISTRY, 2006, 26 (07) : 946 - 949
  • [42] Delayed therapy of experimental global cerebral ischemia with acetyl-L-carnitine in dogs
    Rosenthal, RE
    Bogaert, YE
    Fiskum, G
    NEUROSCIENCE LETTERS, 2005, 378 (02) : 82 - 87
  • [43] ACETYL-L-CARNITINE FOR SYMPTOMATIC DIABETIC NEUROPATHY
    QUATRARO, A
    ROCA, P
    DONZELLA, C
    ACAMPORA, R
    MARFELLA, R
    GIUGLIANO, D
    DIABETOLOGIA, 1995, 38 (01) : 123 - 123
  • [44] Acetyl-L-carnitine ineffective in treatment of CIPN
    Granovetter, Michael
    LANCET ONCOLOGY, 2013, 14 (08): : E299 - E299
  • [45] Acetyl-L-carnitine and peripheral neuropathy - Foreword
    Sima, Anders A. F.
    CNS DRUGS, 2007, 21 : 1 - 2
  • [46] METABOLISM AND DISPOSITION OF INTRAVENOUSLY ADMINISTERED ACETYL-L-CARNITINE IN HEALTHY-VOLUNTEERS
    MARZO, A
    MARTELLI, EA
    URSO, R
    ROCCHETTI, M
    RIZZA, V
    KELLY, JG
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1989, 37 (01) : 59 - 63
  • [47] Acetyl-L-carnitine reduces the infarct size and striatal glutamate outflow following focal cerebral ischemia in rats
    Jalal, Fakhreya Yousuf
    Boehlke, Mark
    Maher, Timothy J.
    NEUROPROTECTIVE AGENTS, 2010, 1199 : 95 - 104
  • [48] The action of acetyl-L-carnitine in dopaminergic neurotransmission
    Cunha, Lidia
    Szigeti, Krisztian
    Mathe, Domokos
    Metello, Luis
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [49] Acetyl-L-carnitine for patients with hepatic encephalopathy
    Marti-Carvajal, Arturo J.
    Gluud, Christian
    Arevalo-Rodriguez, Ingrid
    Elena Marti-Amarista, Cristina
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (01):
  • [50] Acetyl-L-Carnitine in Neuropathic PainExperimental Data
    Santina Chiechio
    Agata Copani
    Robert W. Gereau
    Ferdinando Nicoletti
    CNS Drugs, 2007, 21 : 31 - 38